Edit |   |
---|---|
Antigenic Specificity | PCSK9, Human (Evolocumab biosimilar) |
Clone | Evolocumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG2 lambda |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human PCSK9 Recombinant Antibody (Evolocumab). Evolocumab (trade name Repatha) is a monoclonal antibody medication designed for the treatment of hyperlipidemia. Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9). |
Immunogen | n/a |
Other Names | Anti-PCSK9 Recombinant Antibody, Research Grade Evolocumab, Anti-Human PCSK9 Recombinant Antibody(Evolocumab), AMG 145, Anti-PCSK9, Antibody Drug Analogues, Monoclonal Antibody, YR1294, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1256937-27-5 |
Catalog # | YR1294 |
Price | please inquire |
Order / More Info | PCSK9, Human (Evolocumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |